The nimbleness of biotechs makes them well suited to implementing QbD. Here's how to get started.
Todd Hein
Advertisement
Todd Hein is the senior director of life sciences at Oracle Corporation
Articles by Todd Hein
Advertisement
Latest Updated Articles
QbD: A Roadmap to AdoptionPublished: January 1st 2010 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Novartis–Avidity Biosciences Deal Highlights Next-Gen RNA Manufacturing Potential
2
AI-Driven Organ-on-Chip Platforms Are Changing the Game in Bio/Pharma R&D
3
Q&A: An Evolution in Enzyme Engineering with Zymvol’s Marina Cañellas
4
Welcome to CPHI Frankfurt 2025
5
